Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
IPO Year: 2021
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/22/2025 | $5.00 | Buy | Alliance Global Partners |
| 12/16/2024 | $4.30 | Hold | TD Cowen |
| 10/25/2024 | $5.00 | Buy | Canaccord Genuity |
| 5/1/2024 | $10.00 → $8.00 | Outperform | Telsey Advisory Group |
| 7/24/2023 | Outperform → Mkt Perform | Raymond James | |
| 9/9/2022 | $12.00 | Buy | DA Davidson |
| 8/22/2022 | $11.00 | Outperform | Raymond James |
| 8/17/2022 | $11.00 | Buy | Jefferies |
| 7/19/2022 | $13.00 | Outperform | Telsey Advisory Group |
A Scientific Breakthrough in Skin Renewal: A Clinically Proven Dual-Action, Slow-Release, Overnight Skin Renewal Cream for a Resurfaced, Smoother, and More Even-Looking Complexion NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), the fastest-growing professional skincare brand in the U.S. in 2024* and a subsidiary of Waldencast plc, (NASDAQ:WALD) ("Waldencast"), proudly introduces its latest breakthrough: Retinol + PHA Refining Night Cream. This advanced formulation is engineered to optimize skin renewal by leveraging the efficacy of Entrapped Retinol with the scientifically proven gentle exfoliating properties of Polyhydroxy Acid (PHA) Gluconolactone. This syne
Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024 Milk Makeup expands its distribution to Ulta Beauty Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt maturity LONDON, March 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating res
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. Management will host a conference call to discuss its Fourth Quarter and Fiscal Year 2024 results on March 19, 2025 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be we
LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced its participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit being held on February 26, 2025 in New York, New York. Michel Brousset, Founder and Chief Executive Officer will participate in a fireside chat presentation on Wednesday, February 26, 2025 at 2:45 p.m. Eastern Standard Time and host meetings with investors throughout the day. The fireside chat presentation will be webcast live and available for replay on the Company's Investor Relations website at https://ir.waldencast.com/news-events/ev
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical ("Obagi"), a leader in advanced skincare innovation and the originator of medical-grade skincare, proudly unveils the latest groundbreaking additions to its highly regarded SUZANOBAGIMD® collection. The new products - Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream - offer cutting-edge solutions to address common skincare concerns such as skin discoloration and brightening, oxidative stress, and skin hydration to maintain a healthy skin barrier function. Formulated to be safe and effective for all skin types—whether sensitive, oily, dry, or somewhere in between—Obagi's inclusive approach ensures that ever
LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events. For the fourth quarter and full fiscal year 2024, the Company plans to issue a press release detailing its financial performance after the U.S. stock market closes on Tuesday, March 18th, 2025. The Company's manag
LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, today announced its participation in the 2025 International Master Course on Aging Science (IMCAS) World Congress, which will be held in Paris from January 30, 2025 to February 1, 2025. The IMCAS World Congress is one of the most highly anticipated events in the dermatology, plastic surgery, and aging science community. It gathers industry leaders and executives to discuss the latest breakthroughs, innovations, and business opportunities. Michel Brousset, Founder and Chief Executive Officer, will participate in a capital markets roundtable where he wi
The New York City based award-winning clean color cosmetics brand will expand to select Ulta Beauty stores nationwide and online, marking a significant milestone since its debut in 2016 NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ:WALD) platform, is thrilled to announce an expansion into the nation's largest beauty retailer, Ulta Beauty. Beginning this spring, Milk Makeup's cult-favorite products, including the 13x award-winning Hydro Grip Primer and internet-breaking Cooling Water Jelly Tints will be available in 600+ Ulta Beauty stores nat
WHITE PLAINS, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today announced that the Company will participate in investor meetings and host a presentation at the ICR Conference 2025 being held at The Grande Lakes Orlando in Orlando, Florida on January 13, 2025. Michel Brousset, Founder and Chief Executive Officer, and Manuel Manfredi, Chief Financial Officer, will give the presentation on Monday, January 13, 2025 at 9:30 a.m. Eastern Standard Time. The presentation will be available live and for replay on the Investor Relations page on the company's website at www.ir.waldencast.com.
$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 ("Q3 2024") and nine months ended September 30, 2024 ("Nine Months 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brouss
SC 13D/A - Waldencast plc (0001840199) (Subject)
SC 13G - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13D/A - Waldencast plc (0001840199) (Subject)
SC 13D/A - Waldencast plc (0001840199) (Subject)
SC 13D - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
SC 13G/A - Waldencast plc (0001840199) (Subject)
Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024 Milk Makeup expands its distribution to Ulta Beauty Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt maturity LONDON, March 18, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating res
LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. Management will host a conference call to discuss its Fourth Quarter and Fiscal Year 2024 results on March 19, 2025 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be we
LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at https://ir.waldencast.com/ approximately 2 weeks prior to the events. For the fourth quarter and full fiscal year 2024, the Company plans to issue a press release detailing its financial performance after the U.S. stock market closes on Tuesday, March 18th, 2025. The Company's manag
$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2 2024+45.5% Obagi Medical and +23.5% Milk Makeup vs Q3 2023Adjusted EBITDA of $11.4 million, up +134.0% vs Q3 2023 LONDON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended September 30, 2024 ("Q3 2024") and nine months ended September 30, 2024 ("Nine Months 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brouss
LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform provided the details for its Third Quarter Fiscal 2024 conference call and webcast. As previously announced, the Company will issue its Third Quarter Fiscal 2024 results on November 20, 2024 after the close of the U.S. market. Management will host a conference call to discuss its Third Quarter Fiscal 2024 results on November 21, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and include
$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk Makeup vs Q2 2023 Adjusted EBITDA of $6.3 million, up +64.5% vs Q2 2023 NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the three months ended June 30, 2024 ("Q2 2024") and six months ended June 30, 2024 ("H1 2024") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, provided second quarter and first half fiscal 2024 earnings conference call and webcast information. As previously announced, the Company will report second quarter and first half fiscal 2024 earnings on August 27th, after the close of the U.S. stock market. The Company will conduct a conference call to discuss its earnings results on Wednesday, August 28, 2024 at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call wi
WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast dates. On Tuesday, August 27, 2024, after the U.S. stock market closes, the Company plans to issue a press release detailing its financial performance for the second quarter and first half of fiscal 2024. The Company's management team will conduct a conference call and webcast with slide presentation to discuss its results, strategy and outlook on Wednesday, August 28, 2024 at 8:30am ET. On Wednesday, November 20, 2024, after the U.S. stock market closes, the Company plans to
$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted EBITDA of $11.4 million, up +12.9% vs Q1 2023 WHITE PLAINS, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ:WALD) ("Waldencast" or the "Company"), a global multi-brand beauty and wellness platform, today reported operating results for the quarter ended March 31, 2024 ("Q1 2024 Financials") on Form 6-K to the U.S. Securities and Exchange Commission, which are also available on the Company's investor relations site at http://ir.waldencast.com/. Michel Brousset, Waldencast Founder and CEO, said: "We had a strong start to the year, growing 21.0% in Comparable Net Rev
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform, announced that it will release its first quarter fiscal 2024 earnings results before the U.S. stock market opens on Tuesday, May 21, 2024. The Company will conduct a conference call to discuss its earnings results on the same day at 8:30am ET. Investors and analysts interested in participating in the conference call are invited to dial (877) 704-4453 or (201) 389-0920 for international callers. The conference call will be webcast live and can be accessed at https://ir.waldencast.com/. A replay of the webcast will remain available on the website for 90
4 - Waldencast Acquisition Corp. (0001840199) (Issuer)
3 - Waldencast Acquisition Corp. (0001840199) (Issuer)
3 - Waldencast Acquisition Corp. (0001840199) (Issuer)
20-F - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
20-F/A - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
6-K - Waldencast plc (0001840199) (Filer)
The New York City based award-winning clean color cosmetics brand will expand to select Ulta Beauty stores nationwide and online, marking a significant milestone since its debut in 2016 NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Milk Makeup, the trailblazing clean beauty brand celebrated for its iconic, high-performance formulas, inclusive ethos and part of the Waldencast plc (NASDAQ:WALD) platform, is thrilled to announce an expansion into the nation's largest beauty retailer, Ulta Beauty. Beginning this spring, Milk Makeup's cult-favorite products, including the 13x award-winning Hydro Grip Primer and internet-breaking Cooling Water Jelly Tints will be available in 600+ Ulta Beauty stores nat
NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast" or "the Company"), a global multi-brand beauty and wellness platform, today announced the formation of a new Creative Council. The interdisciplinary team of industry disruptors will come together to help Waldencast stay ahead of the curve by ideating on long-term macro and micro-trends in the beauty and wellness industry, and to ensure the Company evolves to meet customer needs now and in the future. The Creative Council will focus on what is next in beauty, wellness, and culture. The goal of the powerhouse group is to provide a pulse on trends and become the dreamers and makers of what these industrie
LONG BEACH, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC ("Obagi"), a leader in skincare innovation and the originator of medical-grade skincare, is thrilled to announce the appointment of Dr. Suzan Obagi as the Company's first-ever Chief Medical Director. Obagi is a subsidiary of Waldencast plc, (NASDAQ:WALD) ("Waldencast"), a global multi-brand beauty and wellness platform and publicly listed company. Dr. Obagi brings a wealth of experience and expertise to her role, further solidifying Obagi's commitment to providing advanced, transformative skincare solutions. Dr. Suzan Obagi is a world-renowned, leading board-certified dermatologist and cosmetic surgeon, recogni
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Waldencast plc (NASDAQ:WALD) investors that a lawsuit was filed on behalf of investors that purchased Waldencast securities. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. Waldencast revealed on January 31, 2024, that Philippe Gau
NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ:WALD) ("Waldencast" or "the Company"), a global multi-brand beauty and wellness platform, announced today that Manuel Manfredi will join the Company as Chief Financial Officer on April 1, 2024. Philippe Gautier, currently Chief Financial Officer and Chief Operating Officer is leaving the Company, effective today. Michel Brousset, Founder and Chief Executive Officer of the Company who had previously assumed the combined roles of Chief Executive Officer and Chief Financial Officer prior to the appointment of Mr. Gautier, will serve as the Company's interim Chief Financial Officer through March 31, 2024. Manuel Manfredi
Alliance Global Partners initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00
TD Cowen initiated coverage of Waldencast plc with a rating of Hold and set a new price target of $4.30
Canaccord Genuity initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $5.00
Telsey Advisory Group reiterated coverage of Waldencast plc with a rating of Outperform and set a new price target of $8.00 from $10.00 previously
Raymond James downgraded Waldencast plc from Outperform to Mkt Perform
DA Davidson initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $12.00
Raymond James initiated coverage of Waldencast plc with a rating of Outperform and set a new price target of $11.00
Jefferies initiated coverage of Waldencast plc with a rating of Buy and set a new price target of $11.00
Telsey Advisory Group initiated coverage of Waldencast Acquisition Corp. with a rating of Outperform and set a new price target of $13.00